title: Comparative genomic and in situ hybridization of germ cell tumors of the infantile testis.
abstract: Chromosomal information on germ cell tumors of the infantile testis, ie, teratomas and yolk sac tumors, is limited and controversial. We studied two teratomas and four yolk sac tumors using comparative genomic hybridization (CGH) and in situ hybridization. No chromosomal anomalies were found in the teratomas by any of the methods, not even after CGH on microdissected tumor cells. All yolk sac tumors showed aneuploidy, loss of parts of 4q and 6q, and gain of parts of 20q. Underrepresentation of parts of 8q and overrepresentation of parts of 3p, 9q, 12p, 17, 19q, and 22 were detected in most cases. In addition, one recurrent yolk sac tumor after a sacral teratoma was studied, showing a highly similar pattern of imbalances. While CGH demonstrated loss of 1p36 in one testicular yolk sac tumor, in situ hybridization revealed loss of this region in all yolk sac tumors. High-level amplification of the 12q13-q14 region was found in one yolk sac tumor. MDM2, of which the encoding gene maps to this chromosomal region, was found in all cases using immunohistochemistry, whereas no p53 could be detected. Accordingly, no mutations within exons 5 to 8 of the p53 gene were observed. These data prove the absence of gross chromosomal aberrations in teratomas of the infantile testis and show a characteristic pattern of gains and losses in the yolk sac tumors. Besides confirmation of previously found anomalies, recurrent losses of 1p21-31 and 4q23-33 and gains of 9q34 and 12p12-13 have not been reported before. While genetic inactivation of p53 seems unimportant in the pathogenesis of these tumors, biochemical inactivation by MDM2 might be involved. These data support the existence of three entities of germ cell tumors of the human testis: teratomas and yolk sac tumors of infants, seminomas and nonseminomas of adolescents and young adults, and spermatocytic seminomas of the elderly, each with its own specific pathogenesis.
authors.affiliation: Pathology/Laboratory for Experimental Patho-Oncology, University Hospital Rotterdam/Daniel, Josephine Nefkens Institute, The Netherlands.
authors.forename: M
authors.initials: M
authors.lastname: Mostert
authors.forename: C
authors.initials: C
authors.lastname: Rosenberg
authors.forename: H
authors.initials: H
authors.lastname: Stoop
authors.forename: M
authors.initials: M
authors.lastname: Schuyer
authors.forename: A
authors.initials: A
authors.lastname: Timmer
authors.forename: W
authors.initials: W
authors.lastname: Oosterhuis
authors.forename: L
authors.initials: L
authors.lastname: Looijenga
mesh_terms: D000782:Aneuploidy; D002875:Chromosomes / Q000235:genetics; D018240:Endodermal Sinus Tumor / Q000235:genetics* / Q000378:metabolism; D020868:Gene Silencing; D016158:Genes, p53 / Q000235:genetics; D006801:Humans; D017403:In Situ Hybridization; D007223:Infant; D008297:Male; D009687:Nuclear Proteins; D009693:Nucleic Acid Hybridization; D011518:Proto-Oncogene Proteins / Q000378:metabolism; D051736:Proto-Oncogene Proteins c-mdm2; D013724:Teratoma / Q000235:genetics* / Q000378:metabolism; D013736:Testicular Neoplasms / Q000235:genetics* / Q000378:metabolism; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism
chemical_list: D009687:Nuclear Proteins; D011518:Proto-Oncogene Proteins; D016159:Tumor Suppressor Protein p53; C497206:MDM2 protein, human; D051736:Proto-Oncogene Proteins c-mdm2